Calls
1
Erez Israeli
CEO, Dr. Reddy's Laboratories
Win Rate
100.0%
return
+1.4%
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jul 30
$11.83
+1.4%
After resolving semaglutide production scale-up issue by November, the company expects very healthy Q3 and Q4 earnings, supported by a weak rupee (costs in rupees, sales in dollars) and a strong product pipeline.
Pharma & Biotech
Showing 1 of 1 calls · sorted by mentions
Choose a mentions count to open ticker posts.
Erez Israeli has 1 trade ideas tracked on Buzzberg across 1 tickers since July 2026. Most covered: RDY.
Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology
